News Release

Printer Friendly Version View printer-friendly version
<< Back
Aralez To Announce Fourth Quarter And Full-Year 2015 Results On March 15, 2016

-Executive Management to Host Conference Call on March 15, 2016 at 8:30 a.m. ET-

MILTON, Ontario, March 1, 2016 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ), today announced that it will report its 2015 fourth quarter and full-year financial results on Tuesday, March 15, 2016, before the opening of the U.S. financial markets. Following the announcement, executive management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results, recent highlights and guidance for 2016 financial results.

Audio Webcast/ Conference Call Details
Date: Tuesday, March 15, 2016
Time: 8:30 a.m. ET
Dial-in (U.S.): 877-407-8037
Dial-in (International): 201-689-8037

A live webcast and audio archive for the event may be accessed from the Investors section of the Aralez website at Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for two weeks.

About Aralez Pharmaceuticals Inc.
Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ and TSX: ARZ) is a global specialty pharmaceutical company focused on delivering meaningful products to improve patients' lives while focusing on creating shareholder value by acquiring, developing and commercializing products primarily in cardiovascular, pain and other specialty areas. Aralez's Global Headquarters is in Ontario, Canada, its US Headquarters is planned to be in Princeton, NJ and the Irish Headquarters is in Dublin, Ireland. More information about Aralez can be found at

Aralez Pharmaceuticals Contact
Nichol L. Ochsner
Executive Director, Investor Relations & Corporate Communications


To view the original version on PR Newswire, visit:

SOURCE Aralez Pharmaceuticals Inc.

Data provided by Nasdaq. Minimum 15 minutes delayed.